204 related articles for article (PubMed ID: 26505327)
1. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
[TBL] [Abstract][Full Text] [Related]
2. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
[TBL] [Abstract][Full Text] [Related]
3. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
[TBL] [Abstract][Full Text] [Related]
4. Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.
Belcaro G; Dugall M; Hosoi M; Ippolito E; Cesarone M; Luzzi R; Cornelli U; Ledda A
Int Angiol; 2014 Feb; 33(1):20-6. PubMed ID: 24452082
[TBL] [Abstract][Full Text] [Related]
5. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
Luzzi R; Belcaro G; Ippolito E
Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
[TBL] [Abstract][Full Text] [Related]
6. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
[TBL] [Abstract][Full Text] [Related]
7. Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation.
Belcaro G; Cornelli U
Int J Angiol; 2017 Jun; 26(2):95-101. PubMed ID: 28566935
[TBL] [Abstract][Full Text] [Related]
8. Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Luzzi R; Hosoi M; Maione C; Cotellese R
Minerva Cardioangiol; 2019 Dec; 67(6):450-455. PubMed ID: 31850725
[TBL] [Abstract][Full Text] [Related]
9. Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry.
Ledda A; Cornelli U; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hu S; Corsi M
Panminerva Med; 2020 Mar; 62(1):13-18. PubMed ID: 32199407
[TBL] [Abstract][Full Text] [Related]
10. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
[TBL] [Abstract][Full Text] [Related]
11. Pycnogenol®-Centellicum® supplementation improves lung fibrosis and post-COVID-19 lung healing.
Cesarone MR; Hu S; Belcaro G; Cornelli U; Feragalli B; Corsi M; Bombardelli E; Cotellese R; Hosoi M; Rosenkvist L
Minerva Med; 2022 Feb; 113(1):135-140. PubMed ID: 34180638
[TBL] [Abstract][Full Text] [Related]
12. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
[TBL] [Abstract][Full Text] [Related]
13. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
[TBL] [Abstract][Full Text] [Related]
15. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
[TBL] [Abstract][Full Text] [Related]
16. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomized, placebo-controlled trial.
Incandela L; Belcaro G; Nicolaides AN; Cesarone MR; De Sanctis MT; Corsi M; Bavera P; Ippolito E; Griffin M; Geroulakos G; Sabetai M; Ramaswami G; Veller M
Angiology; 2001 Oct; 52 Suppl 2():S69-73. PubMed ID: 11666127
[TBL] [Abstract][Full Text] [Related]
17. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-assessed plaque occurrence in the carotid and femoral arteries are independent predictors of cardiovascular events in middle-aged men during 10 years of follow-up.
Davidsson L; Fagerberg B; Bergström G; Schmidt C
Atherosclerosis; 2010 Apr; 209(2):469-73. PubMed ID: 19897198
[TBL] [Abstract][Full Text] [Related]
19. A Noninvasive Sonographic Study of Multisite Atherosclerosis in an Elderly Chinese Population.
Huang M; Hippe DS; Huang L; Zhao X; Luo J; Zeng Q; Yuan C
J Ultrasound Med; 2017 Mar; 36(3):639-647. PubMed ID: 28150376
[TBL] [Abstract][Full Text] [Related]
20. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).
Belcaro G; Nicolaides AN; Ramaswami G; Cesarone MR; De Sanctis M; Incandela L; Ferrari P; Geroulakos G; Barsotti A; Griffin M; Dhanjil S; Sabetai M; Bucci M; Martines G
Atherosclerosis; 2001 Jun; 156(2):379-87. PubMed ID: 11395035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
